Abiomed Announces Q1 FY 2021 Revenue of $165 Million and 21% Operating MarginBusiness Wire • 08/06/20
FDA Issues Emergency Use Authorization for Impella Heart Pumps to Provide Unloading Therapy to COVID-19 PatientsBusiness Wire • 08/04/20
FDA Approves Data Streaming from the Impella Console, Setting the Stage for Artificial Intelligence Algorithms to Further Improve Patient OutcomesBusiness Wire • 07/16/20
Abiomed, Inc. (ABMD) CEO Michael Minogue on Q4 2020 Results- Earnings Call TranscriptSeeking Alpha • 04/30/20